Panel Discussion: Assessing the Most Promising Advances in IBD Biomarkers

Time: 2:45 pm
day: Day One


This is a session dedicated to evaluating the current use, future potential and limitations in a variety of not-yet clinically used biomarkers to get peer insights on the future of biomarkers for IBD and to discuss next steps in the field required for future advances.

Approaches to be discussed:

  • Utilizing metabolomics to profile IBD at scale
  • RNA sequencing – which sequences are the easiest to develop a marker from? How to demonstrate economic value of utilizing said sequences
  • Epigenetic biomarkers
  • Flow/Mass Cytometry
  • Transcriptomics and Proteomics